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Distance From Patients With Schizophrenia and Clinical Depression
Abstract
Objectives. To create a doctor of pharmacy curricular experience that will decrease students’ social barriers to
interaction with and treatment of mentally-ill patients.
Design. We created a survey instrument to measure 4 aspects of students’ conceptions of schizophrenia and
clinical depression: (1) understanding of the medical nature of each disease, (2) understanding of patient
behavior, (3) belief in the efficacy of treatment, and (4) social distance. We delivered this instrument before
and after a neuropsychiatry curriculum including ‘‘peer-level patient presenters’’ in addition to the traditional
first-year pharmacy curriculum.
Assessment. Social-distance scores significantly decreased in first-year pharmacy students who attended peer-
level patient presentations, indicating increased willingness to interact with persons with schizophrenia and
clinical depression. In addition, students’ understanding of the causes of illness, behavior of patients, and most
importantly, efficacy of drug counseling for these diseases increased.
Conclusions. Changes to the curriculum including the addition of peer-level patient presentations can
quantitatively decrease pharmacy students’ social barriers to the treatment of mentally-ill patients.
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Objectives. To create a doctor of pharmacy curricular experience that will decrease students’ social
barriers to interaction with and treatment of mentally-ill patients.
Design.We created a survey instrument to measure 4 aspects of students’ conceptions of schizophrenia
and clinical depression: (1) understanding of the medical nature of each disease, (2) understanding of
patient behavior, (3) belief in the efficacy of treatment, and (4) social distance. We delivered this
instrument before and after a neuropsychiatry curriculum including ‘‘peer-level patient presenters’’ in
addition to the traditional first-year pharmacy curriculum.
Assessment. Social-distance scores significantly decreased in first-year pharmacy students who
attended peer-level patient presentations, indicating increased willingness to interact with persons with
schizophrenia and clinical depression. In addition, students’ understanding of the causes of illness,
behavior of patients, and most importantly, efficacy of drug counseling for these diseases increased.
Conclusions. Changes to the curriculum including the addition of peer-level patient presentations can
quantitatively decrease pharmacy students’ social barriers to the treatment of mentally-ill patients.
Keywords: curriculum, mental illness, social distance, schizophrenia, depression
INTRODUCTION
Pharmacists are generally less interactive with and
less comfortable providing pharmaceutical care services
andmedication instructions tomentally ill patients than to
patients with most other classically ‘‘somatic’’ illnesses.1-4
This observation is particularly alarming considering the
high personal and social cost of mental illness and the
historically high rates of medication noncompliance, and
continues despite findings that medication counseling and
monitoring improves adherence to drug therapy in men-
tally ill patients.5,6
There are several reasons why pharmacists may have
lessened interaction with mentally ill patients. These in-
clude (1) poor understanding of the biological and chemical
nature of the illnesses, (2) poor understanding of the behav-
ior of patients with mental illnesses, (3) an inappropriately
lowbelief in the efficacy of psychiatricmedication and thus
the importance of stable treatment, and (4) increased social
distance from those with mental illnesses.2,7-9
Social distance is a major focus of this study, and was
assessed (1) because of its importance in the fields of
psychology and sociology as a measure of willingness
of a subject to participate in varied relationships with
a person belonging to a stigmatized group and (2) because
it is believed to correspond to actual behavior.8-12 Social
distance toward mentally ill patients has been assessed in
first-year pharmacy students, indicating that studentswith
prior relationships with someone with a mental illness
exhibited less social distance than those without,11 how-
ever, the effect of pharmacy curriculum on reducing so-
cial distance has not been studied.
In order to examine these questions, we have quanti-
tatively measured the impact of a teaching technique uti-
lizing student interaction with ‘‘peer-level patient
presenters,’’ who are patients with mental illness or family
members of these patients.13,14 ‘‘Peer-level’’ indicates that
the presenter has what the student perceives as a social
status equal to or greater than their own. This form of in-
teraction is different from that achieved in the clinic or
pharmacy in which the student is in a position of authority
over the patient. Studies have predominantly shown that
‘‘peer-level’’ patient interactions significantly decrease
prejudicial attitudes,while clinician-to-patient interactions
do not.8,12,13,15,16 In this study, ‘‘peer-level’’ status was
achieved byusing presenterswithgraduate-level education
or work history as a health care professional.
The objective of this study was to determine whether
a teaching technique using peer-level patient presenters
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would be effective in increasing pharmacy students’ per-
ception of the importance of the role of pharmacist coun-
seling in effective treatment of 2 specific mental illnesses
and in decreasing classical measures of social distance
that might impair pharmacy students’ willingness to in-
teract with these patients. These goals correspond to the
American Council for Pharmacy Education competency
standards 13 and 15, which emphasize core curricular
teaching that integrates the elements of knowledge, skills,
attitudes, and values, aswell as assessment and evaluation
of student learning outcomes.17 In addition, in accordance
with the Center for the Advancement of Pharmaceutical
Education’s educational outcomes, our studywas designed
to promote patient-centered care training to pharmacy stu-
dents.18 We describe in this report a curricular approach
designed to achieve the above stated goals, and quantita-
tive data supporting the effectiveness of this curriculum.
DESIGN
To determine whether the technique of peer-level pa-
tient presentation decreases pharmacy students’ social
distance from patients with mental illness and/or
increases their perception of the importance of pharmacist
counseling for these patients, we chose to investigate the
effect of peer-level patient presentations for 2 commonly
encountered mental illnesses with significant social
stigma: schizophrenia and clinical depression. A ques-
tionnaire was designed to specifically measure first-year
pharmacy students’ perception of 5 items that we hypoth-
esized may impact pharmacists’ attitudes toward patients
suffering from schizophrenia and clinical depression
(Figure 1). This questionnaire was administered twice,
before and after pharmacy students completed the curric-
ulum on psychiatric and neurologic illnesses, and data
were analyzed to quantify which measures were changed
by students’ exposure to the peer presenters.
As there was no established survey instrument that
addressed all of the measures we wished to investigate,
a unique instrument was created from established sources
as well as our experience.19 The social distance questions
used were a 4-item derivation of the classic Social Dis-
tance Scale20 as used by Bell8 and Angermeyer.21 The
Bogardus social distance scale was designed to study race
relations and includes several questions probing openness
to immigration of differing groups as well as personal
relationships. This scale has been modified to analyze
perceptions about members of differing national, reli-
gious, and political affiliations,10 the physically handi-
capped,22 and the mentally ill.11 The questions included
in this study were chosen to represent varying levels of
personal relationship (roommate, friend, coworker, and
neighbor) involving social comfort, while excluding pre-
viously used questions that could reflect conceptions of
the competency or reliability of the patient, such as will-
ingness to allow a patient to babysit one’s children.8
The patient behavior and usefulness of medication
questions were derived from those utilized in a study of
British medical students and practitioners.7 The causes of
schizophrenia and clinical depression questions were de-
rived from those utilized in a German study of public
perception of the causal attributions of schizophrenia.21
First-year students enrolled in the Pacific University
School of Pharmacy were asked to voluntarily complete
during class time a 42-item questionnaire at the beginning
and at the end of their curriculum on psychiatric and neu-
rologic illnesses. Questions were designed to measure
students’ perception of the behavior of patients with
schizophrenia and clinical depression (7 questions each);
causes of schizophrenia and clinical depression (5 ques-
tions each); usefulness of medication (2 questions each);
usefulness of pharmacist interaction (3 questions each);
and social distance from patients with schizophrenia and
Figure 1. Proposed factors impacting pharmacists’ interaction with mentally-ill patients
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clinical depression (4 questions each).Amodified version
of the survey is provided in Appendix 1. At the end of the
curriculum, students were also invited to complete an
open-ended question evaluating the use of our peer-level
patient presenter on clinical depression.
The Pacific University School of Pharmacy uses
a modified-block format in which courses are presented
sequentially, 3 days per week, for 6 hours per day. This
allows total immersion in one didactic topic at a time.
Additionally, 1 day every other week, first-year students
attend a professional-skills seminar, and 1 day every other
week they attend early experiential clinical rotations as
pharmacy technicians. As part of our course CNS: Phar-
macology and Medicinal Chemistry with Clinical Corre-
lates, we presented five 6-hour days of curriculum on
neuropsychiatric disorders. During this section we cov-
ered several neuropsychiatric disorders including gener-
alized anxiety disorder, clinical depression, bipolar
disorder, phobia, and schizophrenia. Our instructional
techniques included (1) standard didactic presentation
of current neurophysiological theories of mental illness
and pharmacology, (2) presentations by a clinical psychi-
atrist, and (3) peer-level patient/family presenters.
Clinician presentations on both clinical depression
and schizophrenia utilized a case-study approach, discus-
sing real patients and their therapeutic and clinical histories
in order to portray thewide variability in patient cognition,
emotional response to pharmacotherapy, and response to
pharmaceutical treatment. The clinical presenter also de-
scribed how to positively interact with patients whomany
health care workers find disconcerting to work with.
Peer-level patient/family presenters spoke for both
topics; a patient presenter spoke on clinical depression
while a second speaker discussed a family history of
schizophrenia. The peer-level patient presenter on clinical
depression spokewith startling honesty for 1.5 hours on the
symptomology of the disease, familial and cultural barriers
she faced in accepting diagnosis and treatment, her medi-
cation history, and how she was able to overcome her ill-
ness enough to raise a family, continue her education, and
run a business, while still suffering from recurrent bouts of
depression. Using this technique of self-portrayal, the
speaker attempted to bring a sense of reality and humanity
to the illness. The students continued this dialog by asking
formal questions for30minutes, and several students joined
in a personal conversation with her during the following
break. The family member speaking on schizophrenia dis-
cussed her relationship with her schizophrenic family
member, and how the family was affected by the illness
on a day-to-day basis. Students respondedwithmany ques-
tions ranging from symptomology to personal impact, in-
cluding a tentative question on whether the lecturer was
concerned about a genetic predisposition toward schizo-
phrenia in her children. This question resulted in a dialog in
which students could address their own fears and attitudes
toward mental illness in their families and friends.
The questionnaire was presented in online form uti-
lizing Web Course Tools (WebCT), and students were
given in-class time to complete it. All students in our
program are required to bring a WebCT compatible lap-
top to class each day, and all first-year students had online
access to the questionnaire. The questionnaire was pre-
sented twice, once before their curriculum on psychiatric
and neurologic illnesses and once after.
Data including personal identifiers was downloaded
from theWebCT base into aMicrosoft Excel spreadsheet.
Within this spreadsheet, students’ responses on the pre-
and post-intervention survey instruments were coded and
paired to allow for anonymous analysis. Student data for
the questions on schizophrenia or clinical depressionwere
subdivided according to their response to a question ask-
ing whether they had attended the speaker presentations
for that topic. In order to quantitate changes, data for each
4- or 5-point Likert-scale question was transformed from
verbal descriptions to a numerical scale on which 1
equaled higher percentage,more agreement, ormorewill-
ing, and 4 or 5 equaled lower percentage, less agreement,
or least willing. Changes in group means are presented in
pretest mean/posttest mean ratio form where 3.74/4.24
indicates a mean change toward lower percentage, or less
agreement. Data for each question was analyzed using
a paired, two-tailed t test, to identify differences between
pre- and post-intervention answers. Statistical signifi-
cance was defined as p , 0.05, and only significant
changes are reported in this manuscript.
IRB approval was sought and granted by the Pacific
University Institutional Research Board for the comple-
tion of this study.
ASSESSMENT
Forty-eight students completed both the pre-interven-
tion and post-intervention survey. Thirty-four of the 48
students had attended the presentations on clinical depres-
sion and 14 had not, and 42 had attended the presentations
on schizophrenia and 6 had not.
Students who attended the peer-level family-member
presentation on schizophrenia (n5 42) were less likely to
believe that patients with schizophrenia would be unable
to raise children than they were before completing the cur-
riculum (p, 0.001; pre-curriculum score/ post-curriculum
score5 3.19/4.00), Students alsowere less likely to believe
that patients with schizophrenia are violent than they were
before completing the curriculum (p 5 0.002; 3.69/ 4.31;
Table 1). They indicated significantly more agreement
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with the statement that ‘‘schizophrenia is caused by a brain
disease or chemical imbalance’’ (p , 0.001; 1.74/1.24).
Students showed significantly less agreement that schizo-
phrenia is caused by ‘‘being in a broken home or without
parental affection’’ (p 5 0.020; 3.74/4.24) and although
not significant, students trended to indicate less agree-
ment with statements that it was caused by immoral life-
style, lack of willpower, or stress at work or home.
Students who attended the peer-level family member
presentation on schizophrenia indicated an increased
expectation that patients with schizophrenia would re-
member drug counseling instructions compared to their
pre-intervention expectations (p 5 0.004; 2.88/2.40).
All 4 social distance measures decreased among stu-
dents who attended the peer-level family member presen-
tation on schizophrenia, with significant decreases in the
2 indicators of closest social interaction: students became
more willing to share an apartment with a person with
schizophrenia (p 5 0.018; 2.88/2.55) or introduce a per-
son with schizophrenia to their close circle of friends
(p 5 0.014; 2.26/1.95).
Students who attended the peer-level patient presenta-
tion on clinical depression (n 5 34) showed increased
perception of the severity of the disorder. They were more
likely to believe that patients with depression would be
medicated (p 5 0.032; 2.97/2.65) or hospitalized (p 5
0.002; 4.53/4.00) than they were before completing the
curriculum (Table 2). They indicated significantly more
agreement with the statement ‘‘schizophrenia is caused
by a brain disease or chemical imbalance’’ (p 5 0.002;
1.88/1.41), and less agreement that it is caused by an im-
moral lifestyle (p 5 0.001; 4.06/4.62), lack of willpower
(p5 0.001; 3.74/4.38), or ‘‘being raised in a broken home
or without parental affection’’ (p5 0.013; 2.79/3.41).
After attending the peer-level patient presentation
on clinical depression, students ranked ‘‘good patient-
pharmacist rapport for medication compliance’’ as more
important than they had in the pre-intervention survey
(p 5 0.006; 1.35/1.15).
Students attending the peer-level patient presentation
on clinical depression showed a significant decrease in the
first social distance measure, responding with more will-
ingness to share an apartment with a person with clinical
depression (p 5 0.019; 2.29/1.94) and trended toward
decreased social distance in 2 of the 3 other measures.
Table 1. Questionnaire on Schizophrenia by Students Attending Presentations
Question P Direction of Change Pre-/Post-Interventiona
Percentage of patients unable to raise
children
,0.001b lower % 3.19/4.00
Percentage of patients violent 0.002b lower % 3.69/4.31
Basis of schizophrenia is a brain disease ,0.001b more agreement 1.74/1.24
Basis of schizophrenia is being raised in
broken home
0.021b less agreement 3.74/4.24
Patient’s memory of drug counseling 0.004b remember more 2.88/2.40
Social distance: willingness to share an
apartment
0.018b more willing 2.88/2.55
Social distance: circle of friends 0.014b more willing 2.26/1.95
aA 4 or 5-point Likert scale was used on which 1 5 higher percentage, more agreement, or more willing, and 4 or 5 5 lower percentage, less
agreement, or least willing. Absolute change in score is presented as a pre-test mean/post-test mean ratio
bindicates a p , 0.05 on a two-tailed, paired t test
Table 2. Questionnaire on Clinical Depression by Students Attending Presentations
Question P Direction of Change Pre/Post-Interventiona
Percentage of depression medicated 0.032b higher % 2.97/2.65
Percentage of depression hospitalized 0.002b higher % 4.53/4.00
Basis of depression is a brain disease 0.002b more agreement 1.88/1.41
Basis of depression is immoral lifestyle 0.001b less agreement 4.06/4.62
Basis of depression is lack of will power 0.001b less agreement 3.74/4.38
Basis of depression is being raised in broken home 0.013b less agreement 2.79/3.41
Importance of patient/pharmacist rapport 0.006b more important 1.35/1.15
Social distance: willingness to share an apartment 0.019b more willing 2.29/1.97
aA 4 or 5-point Likert scale was used on which 1 5 higher percentage, more agreement, or more willing, and 4 or 5 5 lower percentage, less
agreement, or least willing. Absolute change in score is presented as a pre-test mean/post-test mean ratio
bindicates a p , 0.05 on a two-tailed, paired t test
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Students who did not attend the peer-level patient/
family presentations on schizophrenia (n5 6) or clinical
depression (n 5 14) showed significant changes only in
measures of perception of the biological basis of the dis-
eases, andnot inmeasuresof belief of thepharmacists’ im-
portance or social distance. The 3 measures that showed
significant change for this student group were increased
agreement that the basis of schizophrenia is a brain dis-
ease (p5 0.042; 2.00/1.17), increased agreement that the
basis of clinical depression is a brain disease (p5 0.013;
1.86/1.36), and less agreement that clinical depression is
due to a lack of willpower (p 5 0.019; 4.21/4.57).
In order to rule out the possibility that students attend-
ing the presentations did so because of an initially more
positive or accepting attitude toward mental illness, we
compared the pre-intervention social distance scores of
students in the attending group with those of students in
the groups not attending. There was no significant differ-
ence in any initial social distance measure between these
groups as measured by Student’s t test (Table 3).
Student feedback to an open-ended question on the
clinical depression presentation indicated that the presen-
tation was extremely helpful. Several students empha-
sized that although the didactic curriculum had taught
about the biological basis of disease, the peer-level patient
presentation cemented the idea that mental illness could
happen to ‘‘anyone’’ and enhanced their feelings of em-
pathy toward patients with mental illnesses.
DISCUSSION
We presented and tested a teaching plan designed to
enhance not only students’ didactic knowledge, but also
their future professional interaction with patients with
mental illnesses.While the use ofpatient speakers has been
reported in general pharmacy education,we have found no
literature describing its use in mental illness education or
quantitating its effect on social distance measures.14
Our use of peer-level patient/family presenters in-
creased students’ qualitative self-reported sense of empa-
thy toward mentally ill patients. Our quantitative data
similarly suggest that our curriculum achieved the stated
goal of increasing pharmacy students’ perception of the
importance of the role of pharmacist counseling in effec-
tive treatment of these disorders, and in decreasing clas-
sical measures of social distance that might impair their
willingness to interact with these patients. Based on stu-
dent feedback, interactionwith peer-level patient present-
ers appeared to be an important component of the
successful change in their attitudes toward mental illness.
Students’ perception of the degree of social impair-
ment caused by/resulting from schizophrenia decreased
as a result of completing the curriculum, while their per-
ception of the degree of social impairment caused by de-
pression increased. We believe that these opposing
changes reflect the misconceptions that students brought
to the classroom, as they showed a higher initial percep-
tion of social impairment for schizophrenia than for de-
pression. These results may reflect an increased
awareness of the seriousness of depression, as well as
a newunderstanding that there aremany high-functioning
persons with schizophrenia
We initially anticipated that there would be pro-
nounced changes in social distance scores, but upon anal-
ysis we found significant changes only for thosemeasures
for which high social distance (over 2.0) was indicated in
the initial questionnaire. These items were those which
measured closer social relationships, ie, roommate or
friend as opposed to coworker or neighbor. These results
are consistent with prior studies on social distance that
report significant change only on items describing close
relationships and not on items describing more distant
social relationships.23
Lastly, while students actually showed less belief in
the usefulness of medications for these diseases (possibly
due to patient and clinician discussions of drug-refractory
cases), they showedmore belief in the overall importance
of patient/pharmacist rapport and the ability of patients to
understand and remember drug counseling. While stu-
dents recognized the clinical limitations of these drugs,
they believed more strongly in the role of the pharmacist
in treating these patients. We do not know whether these
attitudinal changes will translate into successful changes
in patient care. It would be of interest to follow these
students postgraduation and administer questionnaires
Table 3. Pre-Curriculum Social Distance Scores Compared
Between Student Groups Who Attended or Did Not Attend
Peer-Level Patient/Family Presentations
Attended
Did Not
Attend P
Clinical Depression
Question
18 2.29 2.28 0.98
19 1.76 1.71 0.84
20 1.47 1.64 0.39
21 1.82 2.00 0.41
Schizophrenia
Question
18 2.88 2.50 0.27
19 1.93 1.83 0.76
20 1.95 1.5 0.19
21 2.26 1.5 0.06
Lower scores indicate less social distance, higher scores indicate
greater social distance
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to measure self-reported comfort with mentally ill
patients and average time spent on drug-counseling with
these patients.
One of the major barriers to the use of peer-level
patients in the curriculum is the identification of appropri-
ate speakers. Local offices of major national disease asso-
ciations have been helpful in recruiting patient presenters
for schizophrenia, depression, bipolar disorder, andParkin-
son’s disease.The local chapterof theNationalAlliance for
the Mentally Ill (NAMI) has been particularly helpful and
has an established program of patient-presenters.
SUMMARY
A curricular approach using peer-level patient/family
presenters in addition to traditional didactic methods in-
creased pharmacy students’ empathy toward mentally-ill
patients, decreased social distance, and increased stu-
dents’ belief in the overall importance of the patient/phar-
macist relationship in successfully treatingmental illness.
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Appendix 1. Questions on schizophrenia included in a survey instrument to determine knowledge of disease and attitudes toward
persons with mental illness. An identical set of questions was included for clinical depression.
Question and Likert-scale Responses
1. What percentage of people with schizophrenia are medicated?
2. What percentage of people with schizophrenia are hospitalized in a psychiatric institution?
3. What percentage of people with schizophrenia are unable to raise children?
4. What percentage of people with schizophrenia are homeless?
5. What percentage of patients with schizophrenia are on public assistance?
6. What percentage of people with schizophrenia are unable to work full-time?
7. What percentage of people with schizophrenia are violent?
8. Schizophrenia is caused by a brain disease or chemical imbalance. (strongly agree- strongly disagree)
9. Schizophrenia is caused by immoral lifestyle. (strongly agree- strongly disagree)
10. Schizophrenia is caused by lack of will power. (strongly agree- strongly disagree)
11. Schizophrenia is caused by stress at work or home. (strongly agree- strongly disagree)
12. Schizophrenia is caused by being raised in a broken home or without parental affection. (strongly agree- strongly disagree)
13. Medications for schizophrenia restore completely normal function for what percentage of patients?
14. For the average patient, medications for schizophrenia are (very helpful–very unhelpful)
15. How much do you expect a patient with schizophrenia will understand of a pharmacist’s drug counseling instructions? (almost
all- very little)
16. How much do you expect a patient with schizophrenia will remember of a pharmacist’s drug counseling instructions? (almost
all- very little)
17. How important would you rank good patient-pharmacist rapport for medication compliance in schizophrenia? (very important-
very unimportant)
18. For a currently stable, medicated person diagnosed with schizophrenia, how willing would you be to share an apartment with
that person? (very willing- very unwilling)
19. For a currently stable, medicated person diagnosed with schizophrenia, how willing would you be to work alongside that person
at a job? (very willing- very unwilling)
20. For a currently stable, medicated person diagnosed with schizophrenia, how willing would you be to have that person as
a neighbor? (very willing- very unwilling)
21. For a currently stable, medicated person diagnosed with schizophrenia, how willing would you be to introduce that person into
your close circle of friends? (very willing- very unwilling)
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